Specific interactions between functionalised particles and circulating tumour cells

Matthew T. Stamm, Andrew S. Trickey-Glassman, Linan Jiang, Yitshak Zohar

Research output: Contribution to journalArticle

Abstract

Receptor-ligand binding has been one of the more popular approaches to specifically targeting tumour cells. In this work, targeting efficiency was quantitatively characterized using silica particles functionalized with EpCAM antibodies and EpCAM-expressing BT-20 breast cancer cells. The effects of incubation time and particle concentration on the number of functionalised particles bound to target cells were experimentally investigated. The number of bound particles was found to increase with particle concentration, but not necessarily with incubation time. Binding affinity loss because of cell-particle- cell interaction was identified as a limiting mechanism for the number of particles bound to target cells. While cell-surface coverage because of bound particles rises exponentially under low particle concentration, it features a peak value at high particle concentration. The current findings suggest that separation of a bound particle from a cell may be detrimental to cellular binding affinity.

Original languageEnglish (US)
Pages (from-to)18-23
Number of pages6
JournalIET Nanobiotechnology
Volume8
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Circulating Neoplastic Cells
Tumors
Cells
Antibodies
Silicon Dioxide
Ligands
Silica
Cell Communication
Breast Neoplasms

ASJC Scopus subject areas

  • Electrical and Electronic Engineering
  • Electronic, Optical and Magnetic Materials
  • Biotechnology

Cite this

Specific interactions between functionalised particles and circulating tumour cells. / Stamm, Matthew T.; Trickey-Glassman, Andrew S.; Jiang, Linan; Zohar, Yitshak.

In: IET Nanobiotechnology, Vol. 8, No. 1, 2014, p. 18-23.

Research output: Contribution to journalArticle

Stamm, Matthew T. ; Trickey-Glassman, Andrew S. ; Jiang, Linan ; Zohar, Yitshak. / Specific interactions between functionalised particles and circulating tumour cells. In: IET Nanobiotechnology. 2014 ; Vol. 8, No. 1. pp. 18-23.
@article{48598b062d774424a468864ba8b33c60,
title = "Specific interactions between functionalised particles and circulating tumour cells",
abstract = "Receptor-ligand binding has been one of the more popular approaches to specifically targeting tumour cells. In this work, targeting efficiency was quantitatively characterized using silica particles functionalized with EpCAM antibodies and EpCAM-expressing BT-20 breast cancer cells. The effects of incubation time and particle concentration on the number of functionalised particles bound to target cells were experimentally investigated. The number of bound particles was found to increase with particle concentration, but not necessarily with incubation time. Binding affinity loss because of cell-particle- cell interaction was identified as a limiting mechanism for the number of particles bound to target cells. While cell-surface coverage because of bound particles rises exponentially under low particle concentration, it features a peak value at high particle concentration. The current findings suggest that separation of a bound particle from a cell may be detrimental to cellular binding affinity.",
author = "Stamm, {Matthew T.} and Trickey-Glassman, {Andrew S.} and Linan Jiang and Yitshak Zohar",
year = "2014",
doi = "10.1049/iet-nbt.2013.0034",
language = "English (US)",
volume = "8",
pages = "18--23",
journal = "IET Nanobiotechnology",
issn = "1751-8741",
publisher = "Institution of Engineering and Technology",
number = "1",

}

TY - JOUR

T1 - Specific interactions between functionalised particles and circulating tumour cells

AU - Stamm, Matthew T.

AU - Trickey-Glassman, Andrew S.

AU - Jiang, Linan

AU - Zohar, Yitshak

PY - 2014

Y1 - 2014

N2 - Receptor-ligand binding has been one of the more popular approaches to specifically targeting tumour cells. In this work, targeting efficiency was quantitatively characterized using silica particles functionalized with EpCAM antibodies and EpCAM-expressing BT-20 breast cancer cells. The effects of incubation time and particle concentration on the number of functionalised particles bound to target cells were experimentally investigated. The number of bound particles was found to increase with particle concentration, but not necessarily with incubation time. Binding affinity loss because of cell-particle- cell interaction was identified as a limiting mechanism for the number of particles bound to target cells. While cell-surface coverage because of bound particles rises exponentially under low particle concentration, it features a peak value at high particle concentration. The current findings suggest that separation of a bound particle from a cell may be detrimental to cellular binding affinity.

AB - Receptor-ligand binding has been one of the more popular approaches to specifically targeting tumour cells. In this work, targeting efficiency was quantitatively characterized using silica particles functionalized with EpCAM antibodies and EpCAM-expressing BT-20 breast cancer cells. The effects of incubation time and particle concentration on the number of functionalised particles bound to target cells were experimentally investigated. The number of bound particles was found to increase with particle concentration, but not necessarily with incubation time. Binding affinity loss because of cell-particle- cell interaction was identified as a limiting mechanism for the number of particles bound to target cells. While cell-surface coverage because of bound particles rises exponentially under low particle concentration, it features a peak value at high particle concentration. The current findings suggest that separation of a bound particle from a cell may be detrimental to cellular binding affinity.

UR - http://www.scopus.com/inward/record.url?scp=84897548822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897548822&partnerID=8YFLogxK

U2 - 10.1049/iet-nbt.2013.0034

DO - 10.1049/iet-nbt.2013.0034

M3 - Article

C2 - 24888187

AN - SCOPUS:84897548822

VL - 8

SP - 18

EP - 23

JO - IET Nanobiotechnology

JF - IET Nanobiotechnology

SN - 1751-8741

IS - 1

ER -